Journal of Labelled Compounds and Radiopharmaceuticals

Aims & Scope

The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds.

This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo.

The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2024	0.90

Journal Rank

Year	Value
2024	17727

Journal Citation Indicator

Year	Value
2024	143

SJR (SCImago Journal Rank)

Year	Value
2024	0.271

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	56

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Chemistry, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Labeled 2‐deoxy‐D‐glucose analogs. ¹⁸F‐labeled 2‐deoxy‐2‐fluoro‐D‐glucose, 2‐deoxy‐2‐fluoro‐D‐mannose and ¹⁴C‐2‐deoxy‐2‐fluoro‐D‐glucose

  Citation: 350

  Authors: T., C‐N., V., J. S., A. P., M., D. E.

• Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [¹⁸F]fluorides: Improved synthesis of [¹⁸F]GBR‐13119

  Citation: 164

  Authors: Michael S., Michael R., G., Steven A.

• Pd‐ and Pt‐catalyzed H/D exchange methods and their application for internal MS standard preparation from a Sanofi‐Aventis perspective

  Citation: 159

  Authors: Jens, Volker

• Synthesis of N‐(¹¹C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors

  Citation: 141

  Authors: R, C, D, M, C, J, Ma, A

• Deuteration of acetanilides and other substituted aromatics using [Ir(COD)(Cy₃P)(Py)]PF₆ as catalyst

  Citation: 139

  Authors: D., P. R., B.

• Technetium‐99m radiochemistry for pharmaceutical applications

  Citation: 139

  Authors: Dionysia

• Tritium: a coming of age for drug discovery and development ADME studies

  Citation: 125

  Authors: W. J. S., A., R.

• The development and use of novel iridium complexes as catalysts for <i>ortho</i>‐directed hydrogen isotope exchange reactions

  Citation: 122

  Authors: Göran N., William J.

• Remotely-controlled production of the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635, via 11C-carboxylation of an immobilized Grignard reagent

  Citation: 104

  Authors: Julie A., David R., Victor W., Keith G.

• [¹¹C]Carbon monoxide, a versatile and useful precursor in labelling chemistry for PET‐ligand development

  Citation: 104

  Authors: Bengt, Oleksiy, Obaidur

---